Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel oral small molecule GLP-1 receptor agonist (HRS-7535) in healthy subjects

被引：0
|
作者：
Wu, J. [1 ]
Hu, W. [1 ]
Du, Y. [1 ]
Zhang, Q. [1 ]
Zhou, R. [1 ]
Zhang, Q. [1 ]
Qin, H. [1 ]
Ye, Z. [2 ]
Xu, Y. [2 ]
Feng, S. [2 ]
Shu, C. [2 ]
Shen, Y. [2 ]
Fan, Y. [2 ]
机构：
[1] Anhui Med Univ, Phase I Clin Trial Ctr, Affiliated Hosp 2, Hefei, Peoples R China
[2] Jiangsu Hengrui Pharmaceut Co Ltd, Clin Res & Dev, Shanghai, Peoples R China
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
629
引用
收藏
页码：S316 / S317
页数：2
相关论文
共 50 条
  • [21] Efficacy of CT-996, an Oral Small Molecule GLP-1 Receptor Agonist, in Human GLP-1 Receptor Knockin Mice and Obese Cynomolgus Monkeys
    Luo, Jian
    Rodriguez, Ruben
    Hergarden, Anne
    Tracy, Ted
    Lam, Davina
    Garai, Sumanta
    Marshall, Dan
    Hansen, Stig K.
    Chakravarthy, Manu
    [J]. DIABETES, 2024, 73
  • [22] Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
    Charlotte Granhall
    Morten Donsmark
    Thalia M. Blicher
    Georg Golor
    Flemming L. Søndergaard
    Mette Thomsen
    Tine A. Bækdal
    [J]. Clinical Pharmacokinetics, 2019, 58 : 781 - 791
  • [23] Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
    Granhall, Charlotte
    Donsmark, Morten
    Blicher, Thalia M.
    Golor, Georg
    Sondergaard, Flemming L.
    Thomsen, Mette
    Baekdal, Tine A.
    [J]. CLINICAL PHARMACOKINETICS, 2019, 58 (06) : 781 - 791
  • [24] Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects
    Katz, L. B.
    Gambale, J. J.
    Rothenberg, P. L.
    Vanapalli, S. R.
    Vaccaro, N.
    Xi, L.
    Polidori, D. C.
    Vets, E.
    Sarich, T. C.
    Stein, P. P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (05) : 685 - 692
  • [25] A First-in-Human Study of RGT-075, a Novel, Orally Bioavailable, Small-Molecule GLP-1 Receptor Agonist, in Healthy Adult Subjects
    Pirner, Mark A.
    Lin, Jing
    Liu, Feng
    Yao, Lili
    Zettler, Marjorie E.
    Valacer, David J.
    [J]. DIABETES, 2022, 71
  • [26] TOLERABILITY, PHARMACODYNAMICS AND PHARMACOKINETICS OF A NOVEL ANGIOTENSIN-II RECEPTOR ANTAGONIST IN HEALTHY-SUBJECTS
    PIGUET, V
    BIOLLAZ, J
    APPENZELLER, M
    MUNAFO, A
    NUSSBERGER, J
    EGLIN, M
    GOLDBERG, M
    BRUNNER, HR
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 140 - 140
  • [27] Keverprazan, a novel potassium-competitive acid blocker: Multiple oral doses safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects
    Zhou, Sufeng
    Xie, Lijun
    Zhou, Chen
    Wang, Lu
    Chen, Juan
    Ding, Sijia
    Zhu, Bei
    Su, Mei
    Shao, Feng
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 1911 - 1922
  • [28] Safety, pharmacokinetics and pharmacodynamics of selgantolimod, an oral Toll-like receptor 8 agonist: a Phase Ia study in healthy subjects
    Reyes, Maribel
    Lutz, Justin D.
    Lau, Audrey H.
    Gaggar, Anuj
    Grant, Ethan P.
    Joshi, Adarsh
    Mackman, Richard L.
    Ling, John
    Tan, Susanna K.
    Ayithan, Natarajan
    Daffis, Stephane
    Woo, Jacky
    Wu, Peiwen
    Tina Lam
    Fletcher, Simon P.
    Kottilil, Shyamasundaran
    Poonia, Bhawna
    Gane, Edward J.
    Mathias, Anita
    German, Polina
    [J]. ANTIVIRAL THERAPY, 2020, 25 (03) : 171 - 180
  • [29] Multiple-dose pharmacokinetics, pharmacodynamics, safety, and tolerability of the orexin receptor antagonist almorexant in healthy subjects
    Hoever, P.
    de Haas, S.
    Chiossi, E.
    van Gerven, J.
    Dingemanse, J.
    [J]. SLEEP, 2008, 31 : A38 - A38
  • [30] Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults
    Gane, Edward
    Pastagia, Mina
    Schwertschlag, Ullrich
    De Creus, An
    Schwabe, Christian
    Vandenbossche, Joris
    Slaets, Leen
    Fevery, Bart
    Smyej, Ilham
    Wu, Liviawati S.
    Li, Rui
    Siddiqui, Samia
    Oey, Abbie
    Musto, Clark
    Van Remoortere, Pieter
    [J]. ANTIVIRAL THERAPY, 2021, 26 (3-5) : 58 - 68
12345